Loading…

Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients

DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2023-08, Vol.15 (16), p.4102
Main Authors: Al-Ibraheem, Akram, Al-Rasheed, Ula, Mashhadani, Noor, Abdlkadir, Ahmed Saad, Al-Adhami, Dhuha Ali, Ruzzeh, Saad, Istatieh, Feras, Mansour, Areen, Hamdan, Basem, Kheetan, Reem, Al-Shatti, Marwa, Mohamad, Issa, Juweid, Malik E, Abu Sheikha, Areej, Al-Rabi, Kamal, Sykiotis, Gerasimos P, Kreissl, Michael C, Ismael, Taleb, Sultan, Iyad, Abdel-Razeq, Hikmat
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3
cites cdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3
container_end_page
container_issue 16
container_start_page 4102
container_title Cancers
container_volume 15
creator Al-Ibraheem, Akram
Al-Rasheed, Ula
Mashhadani, Noor
Abdlkadir, Ahmed Saad
Al-Adhami, Dhuha Ali
Ruzzeh, Saad
Istatieh, Feras
Mansour, Areen
Hamdan, Basem
Kheetan, Reem
Al-Shatti, Marwa
Mohamad, Issa
Juweid, Malik E
Abu Sheikha, Areej
Al-Rabi, Kamal
Sykiotis, Gerasimos P
Kreissl, Michael C
Ismael, Taleb
Sultan, Iyad
Abdel-Razeq, Hikmat
description DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches.
doi_str_mv 10.3390/cancers15164102
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10452119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A762474423</galeid><sourcerecordid>A762474423</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</originalsourceid><addsrcrecordid>eNptUk1v3CAQtapWTZTm3CtSL-nBCV8Gu5dq5TbdKCslUraHnhDG2EtkQwrY1f7F_qriJlo1UUFiYHjvzQxMlr1H8JyQCl4oaZX2ARWIUQTxq-wYQ45zxir6-p_9UXYawj1MgxDEGX-bHRHOMEcEHme_N872-Vb7EdxNfjazHMDKymEfTADStuDWu966EI0Cl1JF5wNwHVh52STPrYxG2xjALxN34IvpOu3T2cioW7Dd7b0zLailV8a6UX4CK4Bh_kNLD26aoP2c6C4FA3dxavdARhB3Glwb24P1FII2NpGXGkGdVJM5u17X9UdwZWc3zAuswOUhiXfZm04OQZ8-2ZPs--XXbb3ONzffrurVJleUsZg3FSm15mVLSsh1BXVHKVSs5ZIui2xJx4hErayahhOoECGKlpiTrkQEFYqcZJ8fdR-mZtStSrG9HMSDN6P0e-GkEc9vrNmJ3s0CQVpghKqkcPak4N3PSYcoRhOUHgZptZuCwGXBS1oUeIF-eAG9d5NPb_YXxaqC8ZTaAdXLQQtjO5cCq0VUrNJXU04pJgl1_h9Umq0ejXJWdyb5nxEuHgnKuxC87g5FIiiWFhQvWpD8AVw5zwA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2856956727</pqid></control><display><type>article</type><title>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Al-Ibraheem, Akram ; Al-Rasheed, Ula ; Mashhadani, Noor ; Abdlkadir, Ahmed Saad ; Al-Adhami, Dhuha Ali ; Ruzzeh, Saad ; Istatieh, Feras ; Mansour, Areen ; Hamdan, Basem ; Kheetan, Reem ; Al-Shatti, Marwa ; Mohamad, Issa ; Juweid, Malik E ; Abu Sheikha, Areej ; Al-Rabi, Kamal ; Sykiotis, Gerasimos P ; Kreissl, Michael C ; Ismael, Taleb ; Sultan, Iyad ; Abdel-Razeq, Hikmat</creator><creatorcontrib>Al-Ibraheem, Akram ; Al-Rasheed, Ula ; Mashhadani, Noor ; Abdlkadir, Ahmed Saad ; Al-Adhami, Dhuha Ali ; Ruzzeh, Saad ; Istatieh, Feras ; Mansour, Areen ; Hamdan, Basem ; Kheetan, Reem ; Al-Shatti, Marwa ; Mohamad, Issa ; Juweid, Malik E ; Abu Sheikha, Areej ; Al-Rabi, Kamal ; Sykiotis, Gerasimos P ; Kreissl, Michael C ; Ismael, Taleb ; Sultan, Iyad ; Abdel-Razeq, Hikmat</creatorcontrib><description>DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers15164102</identifier><identifier>PMID: 37627130</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Analysis ; Cancer ; Cancer therapies ; Carcinoma ; Development and progression ; Disease control ; Gender ; Geographical variations ; Iodine ; Lymphatic system ; Males ; Medical prognosis ; Medical records ; Metastases ; Metastasis ; Mortality ; Neck ; Observational studies ; Oncology ; Oncology, Experimental ; Papillary thyroid carcinoma ; Patient outcomes ; Patients ; Population studies ; Prognosis ; Radiation ; Survival ; Survival analysis ; Thyroid cancer ; Thyroidectomy ; Tomography ; Tumors ; Ultrasonic imaging</subject><ispartof>Cancers, 2023-08, Vol.15 (16), p.4102</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</citedby><cites>FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</cites><orcidid>0000-0001-5905-6015 ; 0000-0003-2833-6051 ; 0000-0002-2664-1565 ; 0000-0002-0978-4716 ; 0000-0003-0153-9131 ; 0000-0002-9565-4941</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2856956727/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2856956727?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Al-Ibraheem, Akram</creatorcontrib><creatorcontrib>Al-Rasheed, Ula</creatorcontrib><creatorcontrib>Mashhadani, Noor</creatorcontrib><creatorcontrib>Abdlkadir, Ahmed Saad</creatorcontrib><creatorcontrib>Al-Adhami, Dhuha Ali</creatorcontrib><creatorcontrib>Ruzzeh, Saad</creatorcontrib><creatorcontrib>Istatieh, Feras</creatorcontrib><creatorcontrib>Mansour, Areen</creatorcontrib><creatorcontrib>Hamdan, Basem</creatorcontrib><creatorcontrib>Kheetan, Reem</creatorcontrib><creatorcontrib>Al-Shatti, Marwa</creatorcontrib><creatorcontrib>Mohamad, Issa</creatorcontrib><creatorcontrib>Juweid, Malik E</creatorcontrib><creatorcontrib>Abu Sheikha, Areej</creatorcontrib><creatorcontrib>Al-Rabi, Kamal</creatorcontrib><creatorcontrib>Sykiotis, Gerasimos P</creatorcontrib><creatorcontrib>Kreissl, Michael C</creatorcontrib><creatorcontrib>Ismael, Taleb</creatorcontrib><creatorcontrib>Sultan, Iyad</creatorcontrib><creatorcontrib>Abdel-Razeq, Hikmat</creatorcontrib><title>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</title><title>Cancers</title><description>DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches.</description><subject>Analysis</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Carcinoma</subject><subject>Development and progression</subject><subject>Disease control</subject><subject>Gender</subject><subject>Geographical variations</subject><subject>Iodine</subject><subject>Lymphatic system</subject><subject>Males</subject><subject>Medical prognosis</subject><subject>Medical records</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mortality</subject><subject>Neck</subject><subject>Observational studies</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Papillary thyroid carcinoma</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Population studies</subject><subject>Prognosis</subject><subject>Radiation</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Thyroid cancer</subject><subject>Thyroidectomy</subject><subject>Tomography</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptUk1v3CAQtapWTZTm3CtSL-nBCV8Gu5dq5TbdKCslUraHnhDG2EtkQwrY1f7F_qriJlo1UUFiYHjvzQxMlr1H8JyQCl4oaZX2ARWIUQTxq-wYQ45zxir6-p_9UXYawj1MgxDEGX-bHRHOMEcEHme_N872-Vb7EdxNfjazHMDKymEfTADStuDWu966EI0Cl1JF5wNwHVh52STPrYxG2xjALxN34IvpOu3T2cioW7Dd7b0zLailV8a6UX4CK4Bh_kNLD26aoP2c6C4FA3dxavdARhB3Glwb24P1FII2NpGXGkGdVJM5u17X9UdwZWc3zAuswOUhiXfZm04OQZ8-2ZPs--XXbb3ONzffrurVJleUsZg3FSm15mVLSsh1BXVHKVSs5ZIui2xJx4hErayahhOoECGKlpiTrkQEFYqcZJ8fdR-mZtStSrG9HMSDN6P0e-GkEc9vrNmJ3s0CQVpghKqkcPak4N3PSYcoRhOUHgZptZuCwGXBS1oUeIF-eAG9d5NPb_YXxaqC8ZTaAdXLQQtjO5cCq0VUrNJXU04pJgl1_h9Umq0ejXJWdyb5nxEuHgnKuxC87g5FIiiWFhQvWpD8AVw5zwA</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Al-Ibraheem, Akram</creator><creator>Al-Rasheed, Ula</creator><creator>Mashhadani, Noor</creator><creator>Abdlkadir, Ahmed Saad</creator><creator>Al-Adhami, Dhuha Ali</creator><creator>Ruzzeh, Saad</creator><creator>Istatieh, Feras</creator><creator>Mansour, Areen</creator><creator>Hamdan, Basem</creator><creator>Kheetan, Reem</creator><creator>Al-Shatti, Marwa</creator><creator>Mohamad, Issa</creator><creator>Juweid, Malik E</creator><creator>Abu Sheikha, Areej</creator><creator>Al-Rabi, Kamal</creator><creator>Sykiotis, Gerasimos P</creator><creator>Kreissl, Michael C</creator><creator>Ismael, Taleb</creator><creator>Sultan, Iyad</creator><creator>Abdel-Razeq, Hikmat</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5905-6015</orcidid><orcidid>https://orcid.org/0000-0003-2833-6051</orcidid><orcidid>https://orcid.org/0000-0002-2664-1565</orcidid><orcidid>https://orcid.org/0000-0002-0978-4716</orcidid><orcidid>https://orcid.org/0000-0003-0153-9131</orcidid><orcidid>https://orcid.org/0000-0002-9565-4941</orcidid></search><sort><creationdate>20230801</creationdate><title>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</title><author>Al-Ibraheem, Akram ; Al-Rasheed, Ula ; Mashhadani, Noor ; Abdlkadir, Ahmed Saad ; Al-Adhami, Dhuha Ali ; Ruzzeh, Saad ; Istatieh, Feras ; Mansour, Areen ; Hamdan, Basem ; Kheetan, Reem ; Al-Shatti, Marwa ; Mohamad, Issa ; Juweid, Malik E ; Abu Sheikha, Areej ; Al-Rabi, Kamal ; Sykiotis, Gerasimos P ; Kreissl, Michael C ; Ismael, Taleb ; Sultan, Iyad ; Abdel-Razeq, Hikmat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analysis</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Carcinoma</topic><topic>Development and progression</topic><topic>Disease control</topic><topic>Gender</topic><topic>Geographical variations</topic><topic>Iodine</topic><topic>Lymphatic system</topic><topic>Males</topic><topic>Medical prognosis</topic><topic>Medical records</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mortality</topic><topic>Neck</topic><topic>Observational studies</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Papillary thyroid carcinoma</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Population studies</topic><topic>Prognosis</topic><topic>Radiation</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Thyroid cancer</topic><topic>Thyroidectomy</topic><topic>Tomography</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Ibraheem, Akram</creatorcontrib><creatorcontrib>Al-Rasheed, Ula</creatorcontrib><creatorcontrib>Mashhadani, Noor</creatorcontrib><creatorcontrib>Abdlkadir, Ahmed Saad</creatorcontrib><creatorcontrib>Al-Adhami, Dhuha Ali</creatorcontrib><creatorcontrib>Ruzzeh, Saad</creatorcontrib><creatorcontrib>Istatieh, Feras</creatorcontrib><creatorcontrib>Mansour, Areen</creatorcontrib><creatorcontrib>Hamdan, Basem</creatorcontrib><creatorcontrib>Kheetan, Reem</creatorcontrib><creatorcontrib>Al-Shatti, Marwa</creatorcontrib><creatorcontrib>Mohamad, Issa</creatorcontrib><creatorcontrib>Juweid, Malik E</creatorcontrib><creatorcontrib>Abu Sheikha, Areej</creatorcontrib><creatorcontrib>Al-Rabi, Kamal</creatorcontrib><creatorcontrib>Sykiotis, Gerasimos P</creatorcontrib><creatorcontrib>Kreissl, Michael C</creatorcontrib><creatorcontrib>Ismael, Taleb</creatorcontrib><creatorcontrib>Sultan, Iyad</creatorcontrib><creatorcontrib>Abdel-Razeq, Hikmat</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Ibraheem, Akram</au><au>Al-Rasheed, Ula</au><au>Mashhadani, Noor</au><au>Abdlkadir, Ahmed Saad</au><au>Al-Adhami, Dhuha Ali</au><au>Ruzzeh, Saad</au><au>Istatieh, Feras</au><au>Mansour, Areen</au><au>Hamdan, Basem</au><au>Kheetan, Reem</au><au>Al-Shatti, Marwa</au><au>Mohamad, Issa</au><au>Juweid, Malik E</au><au>Abu Sheikha, Areej</au><au>Al-Rabi, Kamal</au><au>Sykiotis, Gerasimos P</au><au>Kreissl, Michael C</au><au>Ismael, Taleb</au><au>Sultan, Iyad</au><au>Abdel-Razeq, Hikmat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</atitle><jtitle>Cancers</jtitle><date>2023-08-01</date><risdate>2023</risdate><volume>15</volume><issue>16</issue><spage>4102</spage><pages>4102-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37627130</pmid><doi>10.3390/cancers15164102</doi><orcidid>https://orcid.org/0000-0001-5905-6015</orcidid><orcidid>https://orcid.org/0000-0003-2833-6051</orcidid><orcidid>https://orcid.org/0000-0002-2664-1565</orcidid><orcidid>https://orcid.org/0000-0002-0978-4716</orcidid><orcidid>https://orcid.org/0000-0003-0153-9131</orcidid><orcidid>https://orcid.org/0000-0002-9565-4941</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2023-08, Vol.15 (16), p.4102
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10452119
source Open Access: PubMed Central; Publicly Available Content Database
subjects Analysis
Cancer
Cancer therapies
Carcinoma
Development and progression
Disease control
Gender
Geographical variations
Iodine
Lymphatic system
Males
Medical prognosis
Medical records
Metastases
Metastasis
Mortality
Neck
Observational studies
Oncology
Oncology, Experimental
Papillary thyroid carcinoma
Patient outcomes
Patients
Population studies
Prognosis
Radiation
Survival
Survival analysis
Thyroid cancer
Thyroidectomy
Tomography
Tumors
Ultrasonic imaging
title Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A38%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Survival%20Analysis%20and%20Prognostic%20Factors%20of%20Arabic%20Patients%20with%20Differentiated%20Thyroid%20Carcinoma:%20A%2020-Year%20Observational%20Study%20at%20the%20King%20Hussein%20Cancer%20Center%20(KHCC)%20Involving%20528%20Patients&rft.jtitle=Cancers&rft.au=Al-Ibraheem,%20Akram&rft.date=2023-08-01&rft.volume=15&rft.issue=16&rft.spage=4102&rft.pages=4102-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers15164102&rft_dat=%3Cgale_pubme%3EA762474423%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2856956727&rft_id=info:pmid/37627130&rft_galeid=A762474423&rfr_iscdi=true